RKDA - Arcadia Biosciences, Inc.
2.03
-0.010 -0.493%
Share volume: 45,408
Last Updated: 03-11-2026
Agriculture/Agricultural Production – Crops:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.04
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-13-2024 | 11-12-2024 | 03-25-2025 | 05-08-2025 | 08-14-2025 | 11-07-2025 | |
| Assets | ||||||||
| Total Assets | 16.046 M | 17.369 M | 15.241 M | 13.517 M | 12.990 M | 7.788 M | 8.584 M | |
| Current Assets | 11.642 M | 12.434 M | 10.711 M | 9.242 M | 8.846 M | 7.579 M | 8.387 M | |
| Inventories | 1.831 M | 978.000 K | 835.000 K | 904.000 K | 1.285 M | 1.489 M | 1.457 M | |
| Other Current Assets | 15.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 5.184 M | 2.604 M | 2.640 M | 0.000 | 0.000 | 3.067 M | 4.765 M | |
| Total Receivables | 0.000 | 2.599 M | 2.709 M | 3.069 M | 3.579 M | 1.264 M | 831.000 K | |
| Current Cash | 3.317 M | 5.504 M | 3.936 M | 4.242 M | 3.159 M | 1.376 M | 1.120 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 328.000 K | 54.000 K | 55.000 K | 41.000 K | 28.000 K | 12.000 K | 10.000 K | |
| Other Assets | 4.076 M | 4.881 M | 4.475 M | 4.234 M | 4.116 M | 197.000 K | 187.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 16.046 M | 17.369 M | 15.241 M | 13.517 M | 12.990 M | 7.788 M | 8.584 M | |
| Total liabilities | 5.563 M | 5.803 M | 5.092 M | 7.294 M | 4.085 M | 3.255 M | 3.141 M | |
| Total current liabilities | 2.878 M | 2.698 M | 2.328 M | 2.563 M | 2.216 M | 1.839 M | 2.285 M | |
| Accounts Payable | 1.732 M | 1.560 M | 1.692 M | 2.108 M | 1.895 M | 1.558 M | 2.015 M | |
| Other liabilities | 2.685 M | 3.105 M | 2.764 M | 4.731 M | 1.869 M | 1.416 M | 856.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.685 M | 3.105 M | 2.764 M | 4.731 M | 1.869 M | 1.416 M | 856.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 10.621 M | 11.704 M | 10.287 M | 6.223 M | 8.905 M | 4.533 M | 5.443 M | |
| Common stock | 284.723 M | 284.825 M | 284.984 M | 285.101 M | 285.184 M | 285.270 M | 285.324 M | |
| Retained earnings | -274.263 M | -273.202 M | -274.814 M | -278.878 M | -276.279 M | -280.737 M | -279.881 M |